Add to MyYahoo RSS

Biotech News

Biotech news continually updated from thousands of sources around the net.

2 hrs ago |

AbbVie 2Q profit climbs 2.8 percent

Drugmaker AbbVie Inc.'s second-quarter profit increased nearly 3 percent and beat analysts' expectations, as sales soared for the world's top-selling drug, Humira.


Related Topix: North Chicago, IL, Shire plc

5 hrs ago | WTAE-TV Pittsburgh

CDC lab resumes shipping of TB samples

A lab crucial to diagnosing cases of drug-resistant tuberculosis at the Centers for Disease Control and Prevention has reopened, according to the CDC.


Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry

7 hrs ago | KRMG-AM Tulsa

Too few teens receiving HPV vaccinations, CDC says

Unacceptably low numbers of teens are getting vaccinated for the human papillomavirus, or HPV, which protects against cervical, throat and mouth cancers, according to the Centers for Disease Control and Prevention.


Related Topix: Vaccinations, Health, HPV, Centers for Disease Control and Prevention, Healthcare Industry

11 hrs ago | UAport

UK Drugmaker Seeks Approval for Malaria Vaccine

GlaxoSmithKline said on Thursday it is applying for regulatory approval for the world's first vaccine against malaria, designed for children in Africa.


Related Topix: Malaria, Medicine, Health, GlaxoSmithKline, Healthcare Industry

Thu Jul 24, 2014

Business Journal

Bristol-Myers Squibb taps Redwood City for expansion, cancer research hub

Bristol-Myers Squibb Co. will create a Redwood City research hub for drugs that stimulate the immune system to fight cancer.


Related Topix: Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Bristol-Myers Squibb, Pharmaceuticals

News Observer

FDA reviewing what could be first biosimilar drug

Nearly five years after Congress passed a law enabling future approval of biosimilars, for the first time the FDA has accepted an application to sell a similar, but not identical, version of a biologic drug.


Related Topix: Healthcare Law, Law, Food and Drug Administration, Medicine, Neupogen, Filgrastim (generic), Amgen, Healthcare Industry

WLFI-TV West Lafayette

Lilly Research Laboratories in Indianapolis.

Eli Lilly and Co. on Thursday reported profit that declined by 39 percent in its second quarter, and beat analysts' expectations.


Related Topix: Eli Lilly, Medicine, Healthcare Industry

KHOU-TV Houston

Bristol 2Q net drops on lower drug sales, charges

Bristol-Myers Squibb Co.' s exit from the diabetes business, plus higher taxes and research spending, combined to slash the drugmaker's second-quarter profit by 38 percent, but the company handily beat Wall Street's muted profit expectations.


Related Topix: Bristol Myers Squibb, Medicine, Healthcare Industry, Diabetes, Health, Oncology

Al Bawaba

U...Uso U O O O Uoe O U O1O U U...Uoeo OaO3O U U U...Uso U O U O3O O 9.3 ...

DP World Limited handled 29.4 million TEU across its global portfolio of container terminals during the first half of 2014, with gross container volumes growing by 9.3% on a like-for-like basis.


Related Topix: Medical Equipment, Medicine, Healthcare Industry, Diagnostic Products

Wed Jul 23, 2014


Republican lawmaker to grill U.S. SEC over Ackman tactics

A U.S. lawmaker will pressure the U.S. Securities and Exchange Commission on Thursday to consider a raft of reforms, after William Ackman's aggressive efforts to take over Allergan Inc raised concerns about loose rules governing disclosure and shareholder voting.


Related Topix: Securities and Exchange Commission, Corporate / Securities Law, Law, US Politics, US News, Edward Royce, Republican, US House of Representatives, US Securities and Exchange Commission, Financial Services, Allergan

San Jose Mercury News

Puma Biotech soars on positive breast cancer drug results

Puma Biotechnology' stock soared Wednesday after the company reported positive trial results for its breast cancer drug, positioning the company as a potential takeover target.


Related Topix: Medicine, Cancer, Health, Breast Cancer, Science / Technology, Healthcare Law, Law, Johnson & Johnson, Business News


Will hepatitis C drug continue blockbuster sales?

Gilead Sciences' $1,000-a-day hepatitis C pill is facing a firestorm of criticism from insurers and lawmakers, but none of those obstacles are likely to stop the Foster City company from reporting blockbuster revenues during the second quarter today.


Related Topix: Medicine, Gilead Sciences, Healthcare Industry, Hepatitis, Health, Startups, CGI Pharmaceuticals, Liver Cancer

Daily World

Head of troubled CDC anthrax lab has resigned

The head of the government lab which potentially exposed workers to live anthrax has resigned, an agency spokesman said Wednesday.


Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry, Influenza

US stocks mixed as earnings reports roll in

Biotechnology stocks were among the biggest gainers. KEEPING SCORE: The Dow Jones industrial average fell 10 points, or 0.1 percent, to 17,104 as of 11:21 a.m. Eastern.


Related Topix: Financial Markets, Science / Technology

GSK cuts earnings forecast after weak 2nd quarter

Drug maker GlaxoSmithKline has cut its full-year earnings expectations as it says its second-quarter profits were hit by currency moves and a fall in sales of its respiratory drugs.


Related Topix: GlaxoSmithKline, Medicine, Healthcare Industry

North County Public Radio

Biotech firm pulls out of Saranac Lake

The Village of Saranac Lake's plan to grow a cluster of biotechnology companies suffered a setback Monday.


Related Topix: Saranac Lake, NY, Science / Technology, Medicine, Myriad Genetics, Healthcare Industry, Lake Placid, NY, Myriad Pharmaceuticals, Lake-Clear, NY


Ghana's progress in biotech, model for Africa - Top scientist

Ghana's progress towards setting up robust biotech policy is a an excellent model that other African countries can emulate, Africa Harvest Chief Executive Officer, Dr Florence Wambugu, said at sixth African Nutritional and Epidemiology Conference .


Related Topix: Science / Technology, Nutrition, Medicine

Tue Jul 22, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The corrected release reads:... )--Great Lakes Dredge & Dock Corporation , the largest provider of dredging services in the United States and a major provider of env... )--Morgan Stanley will host a Fixed Income Investor conference call on Friday, August 1, 2014 at 9:00 a.m. with Ruth Porat - Executive Vice President and Chie... )--Essensa, a ... (more)


Related Topix: Construction, Great Lakes Dredge and Dock, Stanley, Semiconductors, Analog Devices, Osiris Therapeutics

Business Journal

a Second quarter venture capitalist data shows biotechnology investment is strong, for now

Biotech investment is the highest in Massachusetts than it has ever been, yet venture capital experts say the type of companies receiving investment could create problems for the industry down the line.


Related Topix: Science / Technology, Venture Capital, Emerging Technology

West Australian

Exclusive- India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources

Assuming a multiple of between two and three times those sales, the assets on the block could fetch between $3.5 billion and $5.0 billion , the sources said.


Related Topix: GlaxoSmithKline


Biotech Jobs